Catheter Precision Inc.
VTAK
Get informed when a big investor buys or sells
+ FollowMarket Cap$907.6K
Close$
$-0.13
114.1% downside
Current Fair Value
114.1% downsideOvervalued by 114.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $907,598.00 |
|---|---|
| Enterprise Value | $12.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-15.9 |
| Beta | 0.34 |
| Outstanding Shares | 2,191,831,000 |
Return
| Return on Equity | -169.08% |
|---|---|
| Return on Assets | -46.11% |
| Return on Invested Capital | -148.17% |
Valuation & Multiples
| P/E Ratio | -124.17 |
|---|---|
| PEG | 500.25 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.64 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | 1.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-20.90
Average shareholder expectationRevenue Estimate
$1.60 M
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-19.00
Average shareholder expectationRevenue Estimate
$2.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $102,926▼ 17.76% |
| Investors Holding | 12▲ 3.00% |
ESG Score
No data
About Catheter Precision Inc.
74 employeesadvanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we...